This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

PCC 2023 — Pharmaceutical Compliance Congress
Delivered as a Hybrid Event
April 25 - 27, 2023The Ritz-Carlton, Tysons Corner | McLean, VA

David Amendola
Global Compliance Risk Evaluation and Management at Convatec


Seasoned life sciences compliance and investigations professional, with over 20 years’ experience working with industry clients, including pharmaceutical (branded, generic, and over-the-counter), and medical device companies. Extensive experience leading the development and implementation and execution of compliance operations, including third-party and compliance risk management programs, training, and policy development; complex global investigations, including alleged violations of the Foreign Corrupt Practices Act (FCPA) and other potential frauds across a number of industry risk areas, including bribery and corruption, relationships with healthcare practitioners and other third parties, as well as assessing the effectiveness of industry compliance programs.

Agenda Sessions

  • Living in the New Normal—Navigating Compliance and Investigations in a Post-COVID World